Cutting-Edge MedTech: Navigation Sciences CEO on Clear Surgical Margins & Startup Success
Delta: HealthTech Innovators · Roupen Odabashian
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Explore how Navigation Sciences streamlines surgical navigation for lung cancer and other tumors, ensuring precise margins through advanced MedTech solutions. Gain insider insights on FDA pathways, fundraising strategies, and the vital collaboration among startups, researchers, and policymakers driving healthcare innovation.
0:00 – Show Introduction & Host Welcome
0:26 – Guest Introduction (Alan Lucas, Navigation Sciences CEO)
1:00 – Overview: Minimally Invasive Surgical Instruments & Implants
2:28 – What Is Navigation Sciences? Soft-Tissue Navigation Explained
4:32 – Surgical Margins & Why Precision Matters
6:02 – Real-Time Navigation: Electromagnetic Sensors & 3D Modeling
8:10 – Future Applications (Head & Neck, Liver, Neurosurgery)
9:22 – Building & Protecting Intellectual Property
10:15 – Funding & Early-Stage Financing Strategy
12:40 – Roadmap to FDA (Feasibility Study & Next Steps)
14:15 – Founders vs. Investors: Finding the Right Partners
15:50 – The New England Executive Network: Connecting MedTech Leaders
18:18 – Wrap-Up & Closing Remarks
Roupen Odabashian:
LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/
X: https://twitter.com/RoupenMD
Email: [email protected]
Watch Our Podcast on Youtube
#MedTech, #HealthTech, #Startup, #HealthcareInnovation, #SurgicalNavigation, #ClearMargins, #LungCancer, #Fundraising, #FDA, #Collaboration, #MinimallyInvasive, #MedicalDevice, #Innovation, #TechTrends, #HealthcareTech